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TLQP-21 is a neuropeptide which has been implicated in regulation of nociception
and other relevant physiologic functions. Although recent studies identified C3a and
gC1q receptors as targets for TLQP-21, its intracellular molecular mechanisms of
action remain largely unidentified. Our aim was (i) to explore the intracellular signaling
pathway(s) activated by JMV5656, a novel derivative of TLQP-21, in RAW264.7
macrophages, and (ii) to assess linkages of these pathways with its purported receptors.
JMV5656 stimulated, in a dose-dependent fashion, a rapid and transient increase in
intracellular Ca2+ concentrations in RAW264.7 cells; repeated exposure to the peptide
resulted in a lower response, suggesting a possible desensitization mechanism of
the receptor. In particular, JMV5656 increased cytoplasmic Ca2+ levels by a PLC-
dependent release of Ca2+ from the endoplasmic reticulum. STIM proteins and Orai
Ca2+ channels were activated and played a crucial role. In fact, treatment of the
cells with U73122 and thapsigargin modulated the increase of intracellular Ca2+ levels
stimulated by JMV5656. Moreover, in RAW264.7 cells intracellular Ca2+ increases did
not occur through the binding of JMV5656 to the C3a receptor, since the increase of
intracellular Ca2+ levels induced by JMV5656 was not affected by specific siRNA against
C3aR. In summary, our study provides new indications for the downstream effects of
JMV5656 in macrophages, suggesting that it could activate receptors different from the
C3aR.
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INTRODUCTION
Macrophages, the first line of defense in the host, are found in all tissues and contribute to
several physiological functions, including homeostasis, tissue repair, and development (Wynn
et al., 2013; Epelman et al., 2014). Macrophages are also known to participate in different
pathological phenomena by infiltrating tissues in response to inflammatory stimuli, and releasing
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pro-inflammatory cytokines (Hashimoto et al., 2013; Ristoiu,
2013). As well, macrophages are involved in the generation and
maintenance of neuropathic pain (Clark et al., 2013; Ristoiu,
2013; Willemen et al., 2014), a pathological chronic condition
caused by nerve injury, and characterized by increased sensitivity
to mechanical and thermal stimuli (Skaper et al., 2012; Pannell
et al., 2016). Recently, gene expression profile studies have shown
that vgf (non-acronymic) is a frequently upregulated gene in
several models of neuropathic pain (Moss et al., 2008; Maratou
et al., 2009; Riedl et al., 2009; Chen et al., 2013; Lind et al., 2016).
The vgf gene was originally identified in PC12 rat
pheochromocytoma cells (Levi et al., 1985); its expression
is restricted to subpopulations of neurons and neuroendocrine
cells (van den Pol et al., 1989). The vgf gene encodes a
neuropeptide precursor (615 amino acids in human and 617
amino acids in rodents) that is processed by prohormone
convertases (PCs) 1/3 and 2 to produce numerous smaller and
bioactive peptides. TLQP-21 (VGF556−576) is one of the best-
studied and characterized VGF-derived fragments, and regulates
different biological processes, like energy balance, lipolysis, and
gastric functions, as well as reproduction and inflammatory
pain (Bartolomucci et al., 2006; Sibilia et al., 2010; Aguilar et al.,
2013; Fairbanks et al., 2014). In particular, TLQP-21 was found
to activate macrophages through the complement component
C1q receptor (gC1qR), causing mechanical hypersensitivity
in rats (Chen et al., 2013). Other authors have also reported
that TLQP-21, by binding to the complement component
C3a receptor (C3aR), has a role in directing migration of
macrophages (Hannedouche et al., 2013). Since gC1qR and C3aR
are both receptors of the complement system, an integral part of
the innate immunity that mediates responses to inflammatory
triggers (Nesargikar et al., 2012), the involvement of TLQP-21 in
the inflammatory process is suggested.
Recently, a novel derivative of TLQP-21, JMV5656, has been
found to retain biological activity, effectively stimulate increases
in intracellular calcium (Ca2+) levels, and to activate an outward
potassium (K+) current in microglial cells (Rivolta et al., 2017).
Consequently, the purpose of this study was to investigate
intracellular signaling pathways activated by JMV5656 in
RAW264.7 cells, and to evaluate whether this peptide could
bind to C3aR. The data presented here clearly indicate that
in macrophages JMV5656 stimulates intracellular Ca2+ release
from the endoplasmic reticulum (ER) in a phospholipase C
(PLC)-dependent way, most likely by binding a receptor different
from C3aR.
MATERIALS AND METHODS
Chemicals
TLQP-21 (TLQPPASSRRRHFHHALPPAR) and JMV5656
(RRRHFHHALPPAR) were synthesized using conventional
solid phase synthesis and then purified on a C18 reversed phase
column. Each peptide was purified to a purity of at least 96%
by high-performance liquid chromatography (HPLC). Prior to
assay, peptides were first dissolved in ultrapure water, and then
diluted in Hank’s Balanced Salt Solution (HBSS) to final working
concentrations. Cyclosporine A (CsA), thapsigargin (TG),
U73122, 2-aminoethyl diphenylborinate (2-APB), SKF-96365,
YM-58483, and EGTA were purchased from Sigma-Aldrich
(St Louis, MO, United States). C3a was purchased from
Merck Millipore (Billerica, MA, United States). C3a(70−77) was
purchased from D.B.A. Italia (Segrate, Italy).
Cell Cultures
RAW264.7 murine macrophage cells were cultured in Dulbecco’s
Modified Eagle Medium (DMEM; Sigma-Aldrich) supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 100 IU/ml
penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine
(Euroclone, Pero, Italy) under standard cell culture conditions
(37◦C, 5% CO2).
Intracellular Calcium Mobilization Assay
RAW264.7 cells were plated at 40,000 cells/well into black walled,
clear bottom 96-well plates (Greiner Bio One, Kremsmünster,
Austria) and cultured 2 days up to 90–100% confluence. Before
assay, the medium was removed and cells were incubated with
FLUO-4 NW for 40 min at 37◦C and 5% CO2 as previously
described (Molteni et al., 2017). Fluorescence was monitored
every 0.5 s for the preceding 20 s and the 60 s following
stimulation using the multilabel spectrophotometer VICTOR3
(Perkin Elmer, Waltham, MA, United States) (excitation, 485 nm;
emission, 535 nm). Changes in fluorescence corresponded to
changes in intracellular calcium levels. TLQP-21, JMV5656, C3a,
and C3a(70−77) were diluted in HBSS and injected into the wells
by an automated injector system. Where indicated, antagonists
and inhibitors were added at different times before the end of the
incubation with FLUO-4 NW as previously described (Molteni
et al., 2017). Briefly: 2 µM TG, 20 min; 2 µM CsA, 15 min; 10 µM
U73122, 10 min; 75 µM 2-APB, 15 min; 10 µM SKF-96365,
20 min; 10 µM YM-58483, 20 min; and 1 mM EGTA, 30 min.
Before the end of each experiments, cells were stimulated with
10 µM ATP to control for their viability. All experiments were
performed at 37◦C and fluorescence values (F) were normalized
against the baseline acquired immediately before stimulation
(F0).
siRNA Experiments
C3aR siRNA duplex (sense: 5′-GUGUACCAGUAUUUG
UAUAdTdT-3′; antisense: 5′-UAUACAAAUACUGGUACAC
dTdT-3′) was purchased from Eurofins Genomics (Vimodrone,
Italy). To control for non-specific effects of transfection,
the negative control group was transfected with KCa3.1 siRNA
(sense: 5′-CGGAGAAACACGUGCACAAdTdT-3′; antisense: 5′-
UUGUGCACGUGUUUCUCCGdTdT-3′) (Eurofins Genomics).
Transfection was performed in a 12-well or 96-well plate
(Euroclone), depending on the type of the experiments, using
DharmaFECT 4 Transfection Reagent (Thermo-Scientific,
Waltham, MA, United States) according to the manufacturer’s
protocol. Subsequent experiments were performed 24 h after
transfection.
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FIGURE 1 | Effect of JMV5656 and TLQP-21 on intracellular Ca2+ levels in RAW264.7 cells. Cells were loaded with FLUO-4 NW and fluorescence emissions were
measured at 485/535 nm every 0.5 s for the 20 s preceding and the 60 s following the injection of the stimuli. (A) JMV5656 was applied at concentrations ranging
from 1 nM to 10 µM. Ca2+ mobilizing activity is plotted in terms of maximal response obtained at each given concentration in RAW264.7 cells. The 0 was set as the
1F/F0 measured in cells stimulated with the vehicle only. Results are the mean ± SEM of three independent experiments (n = 18). ∗∗∗p < 0.001 vs. 0 concentration
(Tukey’s test). (B) TLQP-21 and JMV5656 (10 µM) were injected at the time indicated by the arrow. Results are the means of measurements obtained in at least six
different wells for each experiment. All experiments were repeated at least three times. One representative experiment is shown.
FIGURE 2 | Effects of different inhibitors on JMV5656-mediated intracellular Ca2+ increase in RAW264.7 cells. Cells were loaded with FLUO-4 NW and treated with
different inhibitors before the stimulation with 1 µM JMV5656. Graphs show intracellular Ca2+ mobilization (expressed as fluorescence intensity) in RAW264.7 cells
stimulated with (A) HBSS (vehicle), JMV5656 alone and JMV5656 in presence of 2 µM CsA (15 min) or 2 µM TG (20 min); and (B) HBSS (vehicle), JMV5656 alone,
and JMV5656 in presence of 10 µM U73122 (10 min) or 75 µM 2-APB (15 min). Data are shown as the mean ± SEM of measurements obtained in three
independent experiments (n = 18). ◦p < 0.05, ◦◦◦p < 0.001 vs. HBSS; ∗∗∗p < 0.001 vs. JMV5656 (Tukey’s test).
Reverse Transcriptase-Polymerase
Chain Reaction (RT-PCR)
Total RNA was extracted from RAW264.7 cells using
EuroGOLD Trifast reagent (Euroclone) and quantified
spectrophotometrically using a Nanodrop R©ND1000 (Thermo-
Scientific). Total RNA was transcribed to cDNA using
M-MLV Reverse Transcriptase (Invitrogen, Carlsbad, CA,
United States). cDNA was amplified by PCR using GoTaq R©G2
DNA Polymerase (Promega, Madison, WI, United States) in
the presence of the following primers (Sigma-Aldrich): C3aR
forward: 5′-CCTTCTCCTTGGCTCACCT-3′; C3aR reverse:
5′-AAATACGGGCACACACATCA-3′; GAPDH forward:
5′-GCCATCAACGACCCCTTCATTG-3′; GAPDH reverse:
5′-TCTGTCATGAGGTTGGCTTTCAG-3′. The amplified
samples were loaded in equal volumes onto 1% agarose gel in
Tris-Acetate-EDTA (TAE) buffer, and then quantified using a
Kodak Digital ScienceTM Image Station 440CF system. C3aR
mRNA levels were normalized to GAPDH levels.
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Western Blotting
RAW264.7 cells were rinsed twice with cold phosphate-buffered
saline (PBS) and harvested in cold lysis buffer (20 mM Tris-
HCl, pH 7.4, 2 mM EDTA, 0.5 mM EGTA) containing a protease
inhibitor cocktail (P8340, Sigma-Aldrich). Cell lysates were
sonicated on ice and centrifuged at 115,000 ×g for 1 h at 4◦C.
After 15–20 min of incubation on ice, pellets were resuspended
in assay buffer (50 mM Tris-HCl, pH 7.4, 2.5 mM EGTA),
and quantified by BCA assay (Thermo-Scientific). Equivalent
amounts of samples were run on precast 4–12% gradient gels
(Twin Helix, Rho, Italy), and transferred to a polyvinylidene
difluoride (PVDF) membrane (GE Healthcare, Little Chalfont,
United Kingdom). Non-specific sites were blocked with 5% dried
fat-free milk dissolved in PBS supplemented with 0.1% Tween-
20 (PBS-T) overnight at 4◦C. After washes in PBS-T, membranes
were incubated with primary antibodies (rabbit anti-C3a receptor
polyclonal antibody, 1:700, Bioss Antibodies, Woburn, MA,
United States; rabbit anti-actin antibody, 1:1500, Sigma-Aldrich)
for 2 h at room temperature (RT). Membranes were then
washed with PBS-T and incubated with a peroxidase-coupled
secondary antibody (goat anti-rabbit IgG, 1:5000, Thermo-
Scientific) for 1 h at RT. Signals were developed with the
enhanced chemioluminescence (ECL) system (GE Healthcare)
and detected with a Kodak imaging system. Image J software
(National Institutes of Health, Bethesda, MD, United States)
was used to quantify protein bands. C3aR protein levels were
normalized for β-actin levels.
Statistical Analysis
Values are expressed as mean ± standard error of the mean
(SEM). Normality of data distribution was assessed by the
Jarque-Bera test. Experiments were independently replicated
at least three times. The statistical significance of differences
between groups was evaluated with Student’s t-test or, when
appropriated, by one-way analysis of variance (ANOVA)
followed by Tukey’s test. A p-value of less than 0.05 was
considered significant.
RESULTS
JMV5656 Stimulates Intracellular Ca2+
Mobilization in RAW264.7 Cells
JMV5656, a novel derivative of TLQP-21, was recently found to
be active in microglial cells (Rivolta et al., 2017). In this research,
we first tested whether JMV5656 was capable of stimulating an
increase of intracellular Ca2+ levels in RAW264.7 macrophages.
To this aim, cells were stimulated with varied concentrations of
JMV5656, ranging from 1 nM to 10 µM. Our results demonstrate
that JMV5656 in the concentration range of 500 nM to 10 µM
(EC50: 0.34 µM) caused a significant rise of intracellular Ca2+
levels, reaching a plateau at higher concentrations (Figure 1A).
Interestingly, JMV5656 was even more effective than TLQP-21 in
inducing an increase in intracellular calcium levels (Figure 1B),
supporting the recent findings that the hot spots for TLQP-21
activity reside in its C-terminal region (Cero et al., 2014).
FIGURE 3 | Modulation of intracellular Ca2+ levels by JMV5656 in the
presence of SOCE antagonists. Cells were loaded with FLUO-4 NW and
treated with different inhibitors before stimulation with 1 µM JMV5656. The
inhibitors of the SOCE process, SKF96365 (10 µM–20 min), YM-58483
(10 µM–20 min) and EGTA (1 mM–30 min), significantly affected
JMV5656-mediated Ca2+ mobilization in RAW264.7 cells. Results are shown
as the means ± SEM of measurements obtained in three independent
experiments (n = 18). ◦◦◦p < 0.001 vs. HBSS; ∗p < 0.05, ∗∗∗p < 0.001 vs.
JMV5656 (Tukey’s test).
JMV5656 Stimulates the Release of Ca2+
From Intracellular Stores in a
PLC-Dependent Way
A universal and well-established mechanism for Ca2+ signaling
is its release from intracellular compartments, where Ca2+
ions are held in reserve (Clapham, 2007). We previously
demonstrated that in CHO cells TLQP-21 induced an increase
of cytoplasmic Ca2+ levels through the release of Ca2+
from the ER (Molteni et al., 2017). Starting from this
observation, we investigated the intracellular transduction
pathways activated by JMV5656 in RAW264.7 cells. The
involvement of mitochondria was ascertained using CsA, an
inhibitor of the mitochondrial permeability transition pore
(mPTP). The incubation of RAW264.7 cells with 2 µM CsA
did not modify either basal fluorescence (Supplementary Figure
S1) nor the increase of intracellular Ca2+ levels induced by
JMV5656 (Figure 2A). These results suggest that the increase
in intracellular calcium does not depend on release from
mitochondrial stores. To evaluate the possibility that Ca2+
released from the ER could also be involved in the mechanism of
action of JMV5656, we measured the effects of the peptide in the
presence of TG, an inhibitor of the sarco/endoplasmic reticulum
Ca2+ ATPase (SERCA). The treatment with 2 µM TG did not
modify basal levels (Supplementary Figure S1) but caused a
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FIGURE 4 | Effects of multiple stimulations with JMV5656 on intracellular Ca2+ levels in RAW264.7 cells. Cells were loaded with FLUO-4 NW and fluorescence
emissions were measured every 0.5 s for the 30 s following injection of the stimuli. (A) The injection of 1 µM JMV5656 was applied three times at 5 min intervals. At
the end of experiments, a stimulation with 10 µM ATP was used to check for cell viability. (B) 1 µM JMV5656 was applied twice at 30 min interval. Results are the
means of measurements obtained in at least six different wells for each experiment. All experiments were repeated at least three times. One representative
experiment is shown.
significant reduction of intracellular Ca2+ mobilization induced
by JMV5656 (about 63% reduction; Figure 2A), confirming
that JMV5656 stimulates the release of Ca2+ from the ER,
but not from mitochondria. Our results also indicate that
Ca2+ mobilization stimulated by JMV5656 is triggered by
the activation of phospholipase C (PLC), since the treatment
of RAW264.7 cells with the antagonist U73122 (10 µM)
induced a partial, approximately 38%, but significant decrease
in JMV5656-induced Ca2+ release from the ER (Figure 2B).
As a further validation, RAW264.7 cells were incubated with
2-APB, that inhibits inositol-1,4,5-trisphosphate receptor (IP3R)-
mediated Ca2+ release from the ER. As shown in Figure 2B,
treatment with 75 µM 2-APB caused a reduction of intracellular
Ca2+ mobilization induced by JMV5656 of about 65% in
RAW264.7 cells. Again, neither U73122 nor 2-APB modified
basal fluorescence (Supplementary Figure S1).
JMV5656 Effects on the Store-Operated
Calcium Entry Process (SOCE)
It is known that Ca2+ depletion from the ER activates Ca2+
entry from outside of the cell through the interaction of
stromal interaction molecule (STIM) proteins and Orai proteins
(Hewavitharana et al., 2007). To evaluate the involvement of
this pathway in JMV5656 activity, we pre-incubated RAW264.7
cells with 10 µM SKF-96365 and 10 µM YM-58483, two specific
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FIGURE 5 | Effect of C3a and C3a(70-77) on intracellular Ca2+ levels in
RAW264.7 cells. (A) Representative PCR amplification for C3aR in RAW264.7
cells. Lane M: molecular weight marker; lane 1: blank, no template control;
lane 2: negative control (N-38 cells); lane 3: RAW264.7 cells. (B) Cells were
loaded with FLUO-4 NW and fluorescence emissions were measured at
485/535 nm every 0.5 s for the 20 s preceding and the 60 s following the
injection of the stimuli. HBSS, JMV5656, C3a, and C3a(70-77) (1 µM) were
injected at the time indicated by the arrow. Results are the means of
measurements obtained in at least six different wells for each experiments. All
experiments were repeated at least three times. One representative
experiment is shown.
STIM- and Orai-blockers. Both compounds did not alter basal
fluorescence (Supplementary Figure S2) but caused a drop
in JMV5656-mediated Ca2+ response of about 41% and 26%,
respectively (Figure 3). Moreover, the treatment of RAW264.7
cells with the extracellular Ca2+ chelator EGTA (1 mM) inhibited
the rise in intracellular Ca2+ concentration by 71% (Figure 3),
suggesting that Ca2+ entry from the extracellular environment
is an important step in the transduction mechanisms activated
by JMV5656. At the end of each experiment, cell viability was
tested by stimulation with 10 µM ATP (Supplementary Figures
S3–S5).
JMV5656 Induces a Homologous
Desensitization Mechanism in RAW264.7
Cells
In a second series of experiments, we investigated whether
RAW264.7 cells could respond to repeated JMV5656 stimulations
given at 5 min intervals. The first administration of 1 µM
JMV5656, as expected, induced a robust increase of intracellular
Ca2+ concentration (Figure 4A). By comparison, second
application of 1 µM JMV5656, 5 min later, stimulated only a
blunted increase in intracellular Ca2+ levels. JMV5656 applied
FIGURE 6 | Repeated C3a(70-77) and JMV5656 stimulations on intracellular
Ca2+ levels in RAW264.7 cells. Cells were loaded with FLUO-4 NW and
fluorescence emissions were measured every 0.5 s for the 30 s following the
injection of the stimuli. (A) 1 µM C3a(70-77) was applied twice at 30 min
interval. JMV5656 (B) and C3a(70-77) (C) were applied after 30 min from
C3a(70-77) and JMV5656, respectively. Results are the means of
measurements obtained in at least six different wells for each experiments. All
experiments were repeated at least three times. One representative
experiment is shown.
a third consecutive time had no effect on cytoplasmic Ca2+
levels (Figure 4A). Subsequent inoculation of cells with 10 µM
ATP, 5 min after the third stimulation with JMV5656, induced a
robust increment in cell fluorescence, indicating that cells were
still viable (Figure 4A). In order to investigate the possibility
that 5 min was insufficient for cells to recover from the first
administration of JMV5656, a separate independent experiment
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was conducted in which a second stimulation with JMV5656
was applied 30 min after the first one. Again, 1 µM JMV5656
injected 30 min after the first stimulation failed to induce an
increase of intracellular Ca2+ levels (Figure 4B), indicating a
possible desensitization mechanism of the receptor after repeated
stimulation with the peptide.
C3a and C3a(70−77) Effects on
Intracellular Ca2+ Levels in RAW264.7
Cells
Recently, C3aR has been identified as the target for TLQP-21
in macrophages and ovary cells (Hannedouche et al., 2013). We
investigated (i) the presence of the C3aR, and (ii) the activity
of C3a and C3a(70−77) peptides in RAW264.7 cells. RT-PCR
demonstrated that RAW264.7 cells expressed high levels of C3aR
mRNA (Figure 5A), and that both C3a and C3a(70−77) (1 µM)
induced an increase of intracellular Ca2+ levels (Figure 5B).
However, 1 µM JMV5656 was able to stimulate a greater
increase of intracellular Ca2+ mobilization compared to both
C3a peptides (Figure 5B). Since the stimulation of Ca2+ levels
induced by C3a and C3a(70−77) was almost superimposable, we
decided to use C3a(70−77) for the next experiments.
C3a(70−77) Does Not Induce a
Desensitization Mechanism in RAW264.7
Cells
In order to investigate whether C3a(70−77) induced, like
JMV5656, a desensitization mechanism of its receptor,
RAW264.7 cells were stimulated with repeated administration
of C3a(70−77) given at 30 min interval. Intracellular Ca2+
levels rose significantly after the first administration of 1 µM
C3a(70−77) (Figure 6A). After 30 min, a second stimulation with
the peptide still induced a significant increase of intracellular
Ca2+ levels (Figure 6A), suggesting that in these cells C3aR does
not undergo to a desensitization process upon C3a stimulation.
No cross-desensitization was observed when 1 µM JMV5656 was
applied 30 min after C3a(70−77) (Figure 6B). In fact, JMV5656
administered as a second stimulation after C3a(70−77) induced
a robust increase in cell fluorescence (Figure 6B). Interestingly,
the second stimulation with C3a(70−77), applied 30 min after
JMV5656, induced a lower but significant increase of intracellular
Ca2+ levels (Figure 6C) in the cells. These data suggest that in
RAW264.7 cells JMV5656 and C3a(70−77) bind to two different
receptors.
JMV5656 Effects Are Not Mediated by
C3aR in RAW264.7 Cells
To confirm the role of C3aR in the transduction pathway
activated by JMV5656, we used specific siRNA to inhibit
the expression of C3aR in RAW264.7 cells. Transfection of
25 mM C3aR siRNA duplex for 24 h significantly reduced C3aR
mRNA (Figure 7A) and protein levels (Figure 7B). Moreover,
siRNA against C3aR reduced the increase of intracellular
Ca2+ levels mediated by 1 µM C3a of about 38%, while no
reduction was observed after 1 µM JMV5656 Ca2+ stimulation
FIGURE 7 | Effect of C3aR siRNA on RAW264.7 cells stimulated with
JMV5656 and C3a(70-77). Graphs show mRNA (A) and protein (B) levels of
C3aR after transfection with 25 mM siRNA for 24 h. Data are shown as the
mean ± SEM of measurements obtained in at least three independent
experiments. ∗∗p < 0.01, ∗∗∗p < 0.001 vs. control (CTRL). (C) After 24 h from
transfection with 25 mM siRNA, cells were loaded with FLUO-4 NW and
fluorescence emissions were measured at 485/535 nm every 0.5 s for the
20 s preceding and the 60 s following the injection of the stimuli. Graphs show
intracellular Ca2+ levels (expressed as fluorescence intensity) in RAW264.7
cells stimulated with HBSS (vehicle), JMV5656, and C3a(70-77) in the absence
or presence of C3aR siRNA. Results are shown as the mean ± SEM of
measurements obtained in three independent experiments (n = 18). ∗p < 0.05
vs. C3a CTRL (Student’s t-test).
(Figure 7C), further indicating that JMV5656 induces an increase
of intracellular Ca2+ levels by binding a receptor different from
the C3aR in RAW264.7 cells.
DISCUSSION
The interest for TLQP-21 as a potential drug is continuously
expanding thanks to its involvement in several physiologic
functions, like energy homeostasis and nociception
(Bartolomucci et al., 2006; Chen et al., 2013; Fairbanks et al.,
2014). Different receptors have been identified as targets for
TLQP-21 (Chen et al., 2013; Hannedouche et al., 2013), and
recently we characterized its intracellular signaling pathway
in CHO cells (Molteni et al., 2017). Additionally, we found
that JMV5656, a short analog of TLQP-21, activates a Ca2+-
dependent increase in outward K+ current in microglial
cells (Rivolta et al., 2017). Consequently, our present study
investigates molecular mechanisms of action of JMV5656
in a macrophage cell line. Our results demonstrate that in
RAW264.7 cells JMV5656 induces a transient increase in free
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intracellular Ca2+. In immune cells, Ca2+ plays an important
role for activation of the immune response. In particular,
in macrophages Ca2+ has been shown to regulate cytokine-
and nitric oxide-synthesis, as well as phagocytosis (Vaeth
et al., 2015). In our experimental setting, JMV5656, in a
dose-dependent manner, significantly stimulated a rapid and
transient increase in intracellular Ca2+ in RAW264.7 cells,
comparably with reports in ovary and immune cells (Cassina
et al., 2013; Chen et al., 2013; Molteni et al., 2017; Rivolta et al.,
2017).
Our results also indicate that increases of intracellular
Ca2+ levels induced by JMV5656 are a consequence of the
release of Ca2+ from the endoplasmic reticulum, as shown
by the treatment of RAW264.7 cells with TG, an inhibitor
of SERCA. Moreover, in RAW264.7 cells the release of
Ca2+ from the reticulum is triggered by the activation of
PLC, since treatment of the cells with the PLC-antagonist
U73122 induced a significant decrease of JMV5656-stimulated
intracellular Ca2+ release. Indeed, U73122 has been shown
to inhibit the hydrolysis of phosphatidylinositol (PPI) to IP3
leading to a decrease in free cytosolic Ca2+ (Yule and Williams,
1992).
PLCs are known to cleave phosphatidylinositol-4,5-
bisphosphate (PIP2) into diacylglycerol (DAG) and IP3.
DAG activates protein kinase C (PKC), while the binding of IP3
to its receptor triggers the release of Ca2+ ions from the ER.
Our results demonstrate that the treatment of RAW264.7 cells
with 2-APB, an IP3R antagonist, greatly reduced the increase
of intracellular Ca2+ levels induced by JMV5656, further
confirming that the binding of the peptide with its receptor
causes the release of Ca2+ from the ER in a PLC-dependent
way.
Following depletion of ER Ca2+, STIM proteins are activated
and translocate to region of the ER in close proximity with
the plasma membrane, where they activate Orai Ca2+ channels
generating a Ca2+ release-activated Ca2+ (CRAC) current
(Soboloff et al., 2012). The SOCE mechanism is common in
macrophages, where Ca2+ influx is supposed to be linked to the
production of reactive oxygen species (ROS) and to be necessary
for the engulfment of apoptotic cells (Desai and Leitinger,
2014). In RAW264.7 cells, we observed a reduction of JMV5656
Ca2+ stimulation following the treatment of the cells with SKF-
96365 and YM-58483, two specific blockers for STIM and Orai,
respectively. Moreover, also the treatment with the extracellular
Ca2+ chelator EGTA reduced the increase of intracellular Ca2+
concentration induced by the peptide. These data suggest that
extracellular Ca2+ represents an important step in the signaling
pathway activated by JMV5656 but is not necessary for JMV5656
activity since intracellular Ca2+ mobilization is still observed.
Extracellular Ca2+ influx, however, has been proposed to be
essential for macrophages activation, including immunity to
infections, phagocytosis, NLRP3 inflammasome activation, and
cytokines production (Rossol et al., 2012; Félix et al., 2013; Liu
et al., 2016). In this respect, further studies are needed to better
understand the role of JMV5656 in mediating the activation
of NLRP3 inflammasome pathway and the resulting immune
response.
Evidence suggests that SOCE activity could be modulated
by the interaction between Orai and Ca2+-activated K+ (KCa)
channels (Chen et al., 2016). Indeed, it has been shown that
persistent Ca2+ influx into the cell through Orai channels
requires an electrical driving force that is sustained by efflux of
K+ ions (Lin et al., 2014). These data are in agreement with
our recent demonstration that JMV5656 is capable of triggering
the activation of a Ca2+-dependent K+ outward current in N9
microglial cells (Rivolta et al., 2017). The opening of K+ channels
on the plasma membrane is important for its hyperpolarization
that permits the persistence of the driving force for Ca2+ to entry
from the extracellular environment to replenish the intracellular
Ca2+ stores (Rivolta et al., 2017).
Repeated administration of JMV5656 to RAW264.7 cells
caused a decreased calcium response, suggesting a possible
desensitization mechanism for JMV5656 receptor. In particular,
JMV5656 induced a homologous desensitization to subsequent
JMV5656 stimulation given at 5 or 30 min intervals, but not to
ATP, indicating that the desensitization only occurred on specific
pathways.
Recently, C3aR has been indicated as possible receptor for
TLQP-21 in rodents (Hannedouche et al., 2013). C3aR is a
G protein-coupled receptor (GPCR) expressed in lung, spleen,
ovary, and intestine. Its expression has been reported also on
myeloid cells, such as dendritic cells, macrophages and microglia,
and on neurons, where it may have a role in central nervous
system (CNS) inflammation and during development (Klos et al.,
2013). Accordingly, our results revealed the expression of C3aR in
RAW264.7 cells. Moreover, C3a and C3a(70−77) peptides induced
an increase of intracellular Ca2+ levels in these cells. However,
unlike JMV5656, repeated administration of C3a(70−77) did not
induce a desensitization mechanism, suggesting the existence of
two different receptors for these peptides in RAW264.7 cells.
Indeed, in our experimental setting, incubation with siRNA
against C3aR decreased intracellular Ca2+ mobilization induced
by C3a but not by JMV5656, confirming the presence of a
receptor different from C3aR, and still unidentified, in RAW264.7
cells for JMV5656. Indeed the RAW264.7 also express significant
amounts of mRNA for gC1qR, which has been proposed to
mediate the effects of TLQP-21 in macrophages (Chen et al.,
2013). We could speculate that JMV5656 is capable to stimulate
both C3aR and gC1qR and possibly other receptor species,
whereas the C3a can stimulate only its specific receptor. Further
studies are needed to clarify how many receptors TLQP-21
can bind and which ones are primarily involved in its biologic
activities.
CONCLUSION
Our research provides new evidence for the downstream effect
of the binding of JMV5656 to its receptor in macrophages, and
suggests the existence of different receptors for this peptide
in rodent cells. Improving knowledge about the intracellular
pathway activated by JMV5656 and the identification of the
human receptor could help to improve the treatment of several
human disorders, including neuropathic pain.
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FIGURE S1 | Effects of different inhibitors on basal fluorescence in RAW264.7
cells. Cells were loaded with FLUO-4 NW and treated with different inhibitors
before the stimulation with HBSS. The lines show intracellular Ca2+ mobilization in
RAW264.7 cells stimulated with HBSS alone and in presence of 2 µM CsA
(15 min), 2 µM TG (20 min), 10 µM U73122 (10 min), or 75 µM 2-APB (15 min).
HBSS was injected at the time indicated by the arrow. Results are the means of
measurements obtained in at least six different wells for each experiment. All
experiments were repeated three times. One representative experiment is shown.
FIGURE S2 | Modulation of basal fluorescence in the presence of SOCE
antagonists in RAW264.7 cells. Cells were loaded with FLUO-4 NW and treated
with different inhibitors before the stimulation with HBSS. The lines show
intracellular Ca2+ mobilization in RAW264.7 cells stimulated with HBSS alone and
in presence of 10 µM SKF-96365 (20 min), 10 µM YM-58483 (20 min), or 1 mM
EGTA (30 min). HBSS was injected at the time indicated by the arrow. Results are
the means of measurements obtained in at least six different wells for each
experiments. All experiments were repeated three times. One representative
experiment is shown.
FIGURE S3 | Effects of repeated stimulations on intracellular Ca2+ levels in
RAW264.7 cells. Cells were loaded with FLUO-4 NW and fluorescence emissions
were measured at 485/535 nm every 0.5 s for the 20 s preceding and the 60 s
following the injection of the stimuli. 10 µM ATP was applied after 30 min from
HBSS. HBSS and ATP were injected at the time indicated by the arrow. Results
are the means of measurements obtained in at least six different wells for each
experiments. All experiments were repeated three times. One representative
experiment is shown.
FIGURE S4 | Repeated JMV5656 and ATP stimulations on intracellular Ca2+
levels in RAW264.7 cells. Cells were loaded with FLUO-4 NW and treated with
different inhibitors (2 µM TG 20 min, 10 µM U73122 10 min, 75 µM 2-APB
15 min) before the stimulation with 1 µM JMV5656. 10 µM ATP was applied after
30 min from JMV5656. JMV5656 and ATP were injected at the time indicated by
the arrow. Results are the means of measurements obtained in at least six
different wells for each experiment. All experiments were repeated three times.
One representative experiment is shown.
FIGURE S5 | Repeated JMV5656 and ATP stimulations on intracellular Ca2+
levels in the presence of SOCE antagonists in RAW264.7 cells. Cells were loaded
with FLUO-4 NW and treated with different inhibitors (10 µM SKF-96365 20 min,
10 µM YM-58483 20 min, 1 mM EGTA 30 min) before the stimulation with 1 µM
JMV5656. 10 µM ATP was applied after 30 min from JMV5656. JMV5656 and
ATP were injected at the time indicated by the arrow. Results are the means of
measurements obtained in at least six different wells for each experiment. All
experiments were repeated three times. One representative experiment is shown.
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